Percutaneous Tenotomy Device
Chronic Tendinopathies (e.g., Tennis Elbow, Plantar Fasciitis, Rotator Cuff)
CommercialActive
Key Facts
Indication
Chronic Tendinopathies (e.g., Tennis Elbow, Plantar Fasciitis, Rotator Cuff)
Phase
Commercial
Status
Active
Company
About TendoNova
TendoNova is a private medical device company commercializing a novel, mechanically oscillating percutaneous tenotomy device for treating chronic tendinopathies like tennis elbow, plantar fasciitis, and rotator cuff issues. The 10-minute in-office procedure is positioned as an alternative to physical therapy, shockwave, or surgery, with clinical data showing 87% of refractory patients reporting positive results. Led by CEO Mark A. Samuels and supported by a board and medical advisors including prominent orthopedic specialists, the company is targeting the large and underserved market of chronic tendon pain.
View full company profile